Cambridge, UK– Abcam’s new engineered knockout cell lysates enable proteomic studies by providing researchers with “true negative” controls. Acquiring reliable off-the-shelf knockout mouse models or cell lines that match specific experimental requirements can be challenging, and often need to be sourced directly from individual researchers or labs. Abcam’s newly-launched collection addresses this issue by providing access to […]

SOUTHPORT, N.C.  – Cygnus Technologies, a Maravai LifeSciences company, announced today that it has achieved ISO 9001:2015 certification. This designation certifies a high level of quality assurance and consistency and will be particularly important to Cygnus Technologies customers engaged in biotherapeutics manufacturing. ISO is the International Organization for Standardization, and certification is a demonstration of Cygnus Technologies’ […]

(Seattle, WA) – Seattle biotech company NanoSurface Biomedical, Inc., a leading provider of biomimetic cell-based assay platforms and services, announced today that it has acquired Silene Biotech, a Seattle biotechnology company focused on stem cell banking and services. This acquisition expands NanoSurface’s capabilities in developing human stem cell-based platforms and technologies to accelerate the development […]

OXGENEâ„¢ announces long-term supply agreement with Abcam for CRISPR based Gene-Editing Services. Oxford. OXGENEâ„¢ (formally known as Oxford Genetics) announces the extension of a successful relationship with Abcam. OXGENEâ„¢ is using its expertise in CRISPR gene-editing to produce hundreds of custom engineered cell lines for antibody validation. In addition, Abcam will offer these cell lines […]

SAN CARLOS, Calif. and YOKOHAMA, Japan – NeuCyte, Inc., and REPROCELL, Inc., today announced a new distributorship. Although NeuCyte has direct sales in North America, this new distributorship will grant REPROCELL customers access to NeuCyte’s pure and ready-to-use iPSC-derived glutamatergic and GABAergic induced neurons (iNs), supplied with astroglia, media and supplements. These components come in kit formats so the user […]

SAN DIEGO, — Nucleus Biologics, a leader in precision cell culture, has announced the broader launch of Conciergeâ„¢ Media Manufacturing Services. This offering fits Nucleus Biologics’ mission “to speed the time from discovery to cure” by offering customization and optimization of cell culture media while providing transparency with the list of components in each media formulation. […]

ASHLAND, Mass. – BioSurfaces, Inc. (BioSurfaces) was awarded a contract from the National Center for Advancing Translational Sciences (NCATS) BioPrinting Lab at the National Institutes of Health to produce 96-well tissue culture plate assemblies that include its proprietary electrospun materials.   The objective is to deliver prototype 96-well or higher plate assemblies that utilize a biodegradable polymer as […]

The iSpecimen Marketplace®provides researchers with unprecedented technology, enabling precision sourcing of  hematopoietic stem and immune cell products from expansive range of partners and donors worldwide LEXINGTON, Mass. —  Devoted to supporting life science researchers who urgently pursue breakthroughs, iSpecimen today announced it has partnered with new providers of diseased and healthy hematologic tissue to offer […]

New platform to combine stem cell and CRISPR gene-editing technology with proven 3D cell culture techniques for producing standardized pancreatic islet disease models.  Schlieren, Switzerland and Cambridge, UK – InSphero AG and DefiniGEN Ltd. today announced that they were awarded a €750K grant from Eurostars to develop a new drug-screening platform based on human pancreatic […]